- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor Which conditions qualify? The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
- News News
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis in America Medical Cannabis Access for Pain Treatment
- Join Join
Yesterday afternoon, both the House of Representatives and the Senate voted on H.J. Res. 123, a Continuing Resolution that keeps the Government open through December 22, 2017. President Trump signed it into law this morning. H.J. Res 123 continues to fund the Federal Government at existing levels and includes all policy provisions as the previous budget. This includes the Rohrabacher-Blumenauer amendment which is the only thing protecting medical cannabis patients from federal interference and prosecution.
This is the second time this year that Congress has approved a continuing resolution to keep the government open, with the first being passed in September.
Negotiations continue on FY18 Appropriations, but the fate of medical cannabis protections after December 22 remain unclear. Earlier this year, the amendment was blocked from being considered by the House Rules committee. Fortunately, the amendment, as introduced by Senator Patrick Leahy remains in consideration for inclusion through the senate version of the bill. To show the strong bipartisan support for this amendment, Americans for Safe Access worked closely with other advocacy groups to get 66 members of the House to sign on to a letter to Congressional Leadership that expresses the desire to maintain protections for state medical cannabis programs. The letter was signed by 28 Republicans and 38 Democrats.
ASA also led a similar letter to appropriations leadership signed by Americans for Safe Access, The Michael J. Fox Foundation, US Pain Foundation, National Multiple Sclerosis Society, Epilepsy Foundation, Tourette Association of America, National Women’s Health Network, and Realm of Caring.
ASA is working hard to ensure that these protections never lapse, but we need your help. Contact your Senator today and tell them to continue to protect medical cannabis patients!